The study identifies neurons as the primary cell subtype sensitive to iACS, with minimal gene expression changes within neurons. Rgs9 is found to be reduced in expression, while unilateral iACS application diminishes its positive neurons in the ipsilateral hemisphere.
Researchers developed a scaffold with controlled pore sizes (200-700 microns) and shapes, using FDM printing technique. The results showed a favourable cellular response and mechanical properties, making it promising for bone defect regeneration.
The tumor microenvironment (TME) is a complex ecosystem surrounding tumors that impacts tumor development, metastasis, and responses to therapies. The review highlights potential therapeutic targets modulating TME components, including immune cells, stromal cells, and ECM proteins, to inhibit tumor progression.
A novel gene-based prognostic tool has been developed to personalize treatment in pediatric acute myeloid leukemia (AML). The five-gene transcriptional signature improves prognostic accuracy and identifies high-risk patients. It also streamlines the panel of genetic markers without compromising predictive efficacy.
The review discusses the mechanism of CRISPR/Cas9 and its challenges in delivering genome editing to cancer cells. Nanotechnology-based delivery systems, such as nanoparticles and exosomes, have shown promise in improving the efficiency and specificity of CRISPR/Cas9 gene editing.
A novel cell-penetrating peptide, Tat-SIRT5-CTM, has been shown to reduce brain infarct area and neuronal loss in a mouse model of ischemic stroke. The peptide inhibits microglia-induced neuroinflammation by promoting ANXA1 nuclear translocation.
Researchers summarize the latest progress in comprehending epigenetic pathways and their dysregulation in cancer development. They discuss the therapeutic potential of epigenetic drugs and combination therapies.
The Chinese expert consensus on CMVD diagnosis and treatment emphasizes standardized methods, six areas for classification, and recommendations for non-invasive diagnostic techniques. The consensus also highlights the need for further research into the pathogenesis of CMVD and its impact on cardiovascular events.
This review highlights the role of single-cell sequencing in HBV-HCC research, shedding light on tumor heterogeneity and immune microenvironment dynamics. The study provides new avenues for visualizing intratumoral and intertumoral heterogeneity, monitoring tumor progression, and preventing cellular deterioration.
A study from China found a high prevalence of high and pathological myopia, yet inadequate patient education. The research highlights the need to improve awareness about these eye diseases to reduce adverse outcomes.
Researchers have designed a nanoparticle-based drug delivery system to target inflammation, addressing issues with conventional anti-inflammatory drugs. The system utilizes targeting moieties to enrich nanoparticles in inflamed tissues, achieving enhanced efficacy.
Ferroptosis is characterized by lipid peroxidation, iron-dependent oxidative stress, and distinct morphological alterations. Recent research highlights the importance of compounds in targeting ferroptosis for therapeutic applications.
Spatial transcriptomics reveals cellular heterogeneity, organizational patterns, and molecular communications foundational to tissue structure and dynamics. The technique has enhanced throughput and resolution, offering a synthesized perspective of biological entities across various levels of detail.
Researchers have identified macrocyclic compounds as a potential solution for targeting proteins critical to tumorigenesis, blocking nearly 80% of cancer's signature characteristic events. Additionally, these small compact molecules can effectively overcome drug resistance by binding to mutant proteins and inhibiting their activities.
Researchers have developed enzydynamic therapy at nanoscale using nanozymes to regulate reactive oxygen species (ROS), which can cause oxidative damage in living organisms. This approach has the potential to treat various diseases, including malignancies, neurodegeneration, and inflammation.